Unknown

Dataset Information

0

Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals.


ABSTRACT:

Objective

Most individuals with two or more islet autoantibodies progress to clinical type 1 diabetes. However, in some individuals, autoantibodies are subsequently lost. Here, our objectives were to determine the frequency of autoantibody loss (reversion) in multiple-autoantibody-positive individuals and to determine the association between reversion and progression to clinical disease.

Research design and methods

We analyzed multiple-autoantibody-positive individuals participating in TrialNet's Pathway to Prevention Study for reversion and determined the effect of reversion on progression to clinical disease using a Cox regression analysis.

Results

Of 3,284 multiple-autoantibody-positive subjects, reversion occurred in 134 (4.1%) and was associated with reduced incidence of clinical disease. Reversion occurred more frequently with older age, lower autoantibody titers, and fewer positive autoantibodies.

Conclusions

Although reversion of multiple-autoantibody positivity is rare, when it occurs, the risk of progressing to clinical disease is reduced. This suggests unknown mechanisms promoting immune remission in some individuals.

SUBMITTER: So M 

PROVIDER: S-EPMC7085807 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7680268 | biostudies-literature
2015-03-03 | GSE66413 | GEO
2015-03-03 | E-GEOD-66413 | biostudies-arrayexpress
| S-EPMC6449004 | biostudies-literature
| S-EPMC5042816 | biostudies-literature
| S-EPMC4682927 | biostudies-literature
| S-EPMC4302258 | biostudies-literature
| S-EPMC6245213 | biostudies-literature
2014-04-10 | E-GEOD-51058 | biostudies-arrayexpress
| S-EPMC7766539 | biostudies-literature